LEADER 02546nam 2200649 450 001 9910797156103321 005 20210524054442.0 010 $a1-118-75459-X 010 $a1-118-75457-3 035 $a(CKB)3710000000411493 035 $a(EBL)2009829 035 $a(SSID)ssj0001482365 035 $a(PQKBManifestationID)11857929 035 $a(PQKBTitleCode)TC0001482365 035 $a(PQKBWorkID)11412820 035 $a(PQKB)10808946 035 $a(MiAaPQ)EBC2009829 035 $a(Au-PeEL)EBL2009829 035 $a(CaPaEBR)ebr11052831 035 $a(CaONFJC)MIL786015 035 $a(OCoLC)899114040 035 $a(MiAaPQ)EBC7147541 035 $a(Au-PeEL)EBL7147541 035 $a(EXLCZ)993710000000411493 100 $a20150521h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 14$aThe Maudsley prescribing guidelines in psychiatry /$fDavid Taylor, Carol Paton, Shitij Kapur 205 $a12th edition. 210 1$aWest Sussex, England :$cWiley Blackwell,$d2015. 210 4$dİ2015 215 $a1 online resource (2455 p.) 300 $aDescription based upon print version of record. 311 $a1-118-75460-3 320 $aIncludes bibliographical references at the end of each chapters and index. 330 $aThe fully updated 12th edition of an essential reference for anyone responsible for prescribing drugs for patients with mental health disorders. A well-respected and widely-used source of information on which drugs to prescribe, which side effects to look out for, how best to augment or switch drugs, and more Provides concise reviews of psychiatric disorders and relevant psychopharmacology, along with general guidance based on the data reviewed and current clinical practice Includes specific guidance for schizophrenia, bipolar disorder, depression, anxiety, substance abuse, and special pop 606 $aPsychopharmacology 606 $aPsychotropic drugs 606 $aDrugs$xPrescribing 615 0$aPsychopharmacology. 615 0$aPsychotropic drugs. 615 0$aDrugs$xPrescribing. 676 $a616.89/18 700 $aTaylor$b David$f1963-,$01570804 702 $aPaton$b Carol 702 $aKapur$b Shitij 712 02$aSouth London and Maudsley NHS Trust, 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910797156103321 996 $aThe Maudsley prescribing guidelines in psychiatry$93853803 997 $aUNINA